The portfolio maintains a cost advantage over competitors, priced within the second-lowest fee quintile among peers.
Fidelity Select Medical Tech and Devcs FSMEX
- NAV / 1-Day Return 62.66 / −0.35 %
- Total Assets 5.3 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.650%
- Distribution Fee Level Low
- Share Class Type No Load
- Category Health
- Investment Style Mid Growth
- Min. Initial Investment —
- Status Open
- TTM Yield —
- Turnover 42%
USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 10:12 PM GMT+0
Morningstar’s Analysis FSMEX
Will FSMEX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 68.4
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Boston Scientific Corp | 14.52 | 782.5 Mil | Healthcare |
Danaher Corp | 13.34 | 719.0 Mil | Healthcare |
Thermo Fisher Scientific Inc | 9.33 | 502.7 Mil | Healthcare |
Intuitive Surgical Inc | 7.98 | 430.3 Mil | Healthcare |
Stryker Corp | 6.33 | 341.1 Mil | Healthcare |
Edwards Lifesciences Corp | 4.30 | 232.0 Mil | Healthcare |
Penumbra Inc | 3.98 | 214.8 Mil | Healthcare |
Abbott Laboratories | 2.96 | 159.4 Mil | Healthcare |
Insulet Corp | 2.86 | 154.2 Mil | Healthcare |
IQVIA Holdings Inc | 2.80 | 151.2 Mil | Healthcare |